Ignite Creation Date:
2025-12-24 @ 3:54 PM
Ignite Modification Date:
2025-12-26 @ 9:14 AM
Study NCT ID:
NCT06157892
Status:
RECRUITING
Last Update Posted:
2025-12-12
First Post:
2023-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Sponsor:
Seagen, a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2029-07-28
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-07-28
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-27
First Submit QC Date:
None
Study First Post Date:
2023-12-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-12
Last Update Post Date Type:
ESTIMATED